The risk of anti-PD-1 mAbs-induced hyperthyroidism was significantly higher compared to that of anti-PD-L1 mAbs-induced hyperthyroidism (OR, 5.36; 95% CI, 2.04–14.08; adjusted p = 0.002) [31]. The gene discussed is CD274; the disease is hyperthyroidism.